↓ Skip to main content

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study

Overview of attention for article published in Journal of Inherited Metabolic Disease, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

policy
1 policy source
twitter
2 X users
patent
3 patents
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
183 Dimensions

Readers on

mendeley
181 Mendeley
citeulike
2 CiteULike